Mechanisms of Action of Intravesical Bacille Calmette-Guérin: Local Immune Mechanisms
Open Access
- 1 September 2000
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 31 (Supplement) , S91-S93
- https://doi.org/10.1086/314066
Abstract
The local immune response to mycobacteria is complex, but mycobacterial antigen presentation by phagocytes to T helper cells is the pivotal interaction. Bacille Calmette-Guérin (BCG) vaccination is associated with the development of antituberculosis immunity but not necessarily with antitumor immunity. Animal studies have shown that an intact host immune system is required for the antitumor activity of BCG. Immunosuppressed and, particularly, T cell-depleted individuals fail to respond to BCG immunotherapy. Clinical and laboratory evidence suggest that the antitumor activity is concentrated at the site of BCG administration, which reinforces the view that local immune mechanisms are responsible for this phenomenon.Keywords
This publication has 19 references indexed in Scilit:
- Induction of ICAM 1 expression on bladder tumours by BCG immunotherapy.Journal of Clinical Pathology, 1994
- Expression and shedding of ICAM‐1 in bladder cancer and its immunotherapyInternational Journal of Cancer, 1993
- Induction of urinary interleukin-1 (IL-1), IL-2, IL-6, and tumour necrosis factor during intravesical immunotherapy with bacillus Calmette-Guérin in superficial bladder cancerCancer Immunology, Immunotherapy, 1992
- Intravesical Evans Strain BCG Therapy: Quantitative Immunohistochemical Analysis of the Immune Response within the Bladder WallJournal of Urology, 1992
- Radio-Immunoassay Detection of Interferon-Gamma in Urine after Intravesical Evans BCG TherapyJournal of Urology, 1990
- Elevations of Cytokines Interleukin-1, Interleukin-2 and Tumor Necrosis Factor in the Urine of Patients after Intravesical Bacillus Calmette-Guerin ImmunotherapyJournal of Urology, 1990
- HLA—DR Expression by High Grade Superficial Bladder Cancer Treated with BCGBritish Journal of Urology, 1989
- Requirement of a Thymus Dependent Immune Response for Bcg-mediated Antitumor ActivityJournal of Urology, 1987
- BCG and CancerNew England Journal of Medicine, 1974
- BCG and CancerNew England Journal of Medicine, 1974